NCT07029776 2026-03-03
MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
University of Arkansas
Phase 2 Not yet recruiting
Clinical Trials
7 trialsNCT06744894 2024-12-20
SIL as Maintenance Therapy in Multiple Myeloma
Navy General Hospital, Beijing
Phase 2 Not yet recruiting
NCT04008888 2019-07-05
a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Unknown
NCT01554852 2018-06-11
Myeloma XI
University of Leeds
Phase 3 Unknown
NCT00580372 2016-09-20
UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma
University of Arkansas
Phase 2 Completed
NCT00480363 2013-07-31
QUIREDEX
PETHEMA Foundation
Phase 3 Completed
NCT00560053 2008-11-27
Pethema Multiple Myeloma 2000
PETHEMA Foundation
Phase 3 Completed